For decades, we’ve treated the decline of BubR1 as a simple marker of senescence—just another casualty of a cell losing its regulatory grip. But looking at recent single-cell longitudinal data, I’m starting to wonder if we’ve got the causality backwards.
Standard dogma frames the Spindle Assembly Checkpoint (SAC) weakening as a result of telomere attrition or systemic DNA damage. I’m seeing evidence, though, that the stoichiometry of the MCC (Mitotic Checkpoint Complex) is far more sensitive to cytosolic fluctuations in chaperone availability than we admit. If the SAC isn’t just ‘failing’ because of age, but is instead being titrated away by the rising burden of misfolded proteins sequestering key components like Mad2, then aneuploidy isn't just a byproduct—it’s the metabolic tipping point that makes recovery impossible.
Consider this:
- Mitotic slippage isn’t just about protein levels; it’s about the kinetic competition between kinetochore-microtubule attachment and proteotoxic interference.
- If we stabilize the SAC in geriatric primary cells, do we see a rescue in proteostatic markers, or does the cell just succumb to a different class of catastrophic error?
I’m increasingly convinced the SAC is the ‘canary in the coal mine’ for cellular stability. We need to stop viewing it as a passive observer and start investigating it as the nexus where mechanical fidelity and protein homeostasis collide. I’m curious if anyone has data on SAC component sequestration during induced proteotoxic stress in young versus aged lineages. Is the failure purely transcriptional, or are we looking at a profound change in the kinetic pool of assembly-competent protein?
Let’s tear this apart. Am I over-indexing on the mechanistic link, or are we missing the forest for the trees?
Sign in to comment.
Comments